Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
TempraMed Technologies Ltd. ( (TSE:VIVI) ) just unveiled an announcement.
TempraMed Technologies Ltd. has announced its listing on the Frankfurt Stock Exchange, marking a significant step in expanding its visibility and strengthening its international presence. This strategic move is expected to enhance trading liquidity and broaden engagement with European investors, particularly in the healthcare innovation sector. Additionally, TempraMed has entered into a corporate awareness agreement with bullVestor Medien GmbH to provide marketing services, aiming to amplify its market presence and effectively communicate its story to investors.
More about TempraMed Technologies Ltd.
TempraMed Technologies Ltd. is a global leader in innovative, temperature-controlled medication storage solutions. The company develops patented, FDA-registered devices that provide hassle-free, 24/7 thermal insulation for life-saving medications without the need for charging or external power. TempraMed’s product line includes VIVI Cap and VIVI Epi, and it operates in North America, Europe, and Asia, focusing on advancing medication protection and adherence.
Average Trading Volume: 5,993
See more insights into VIVI stock on TipRanks’ Stock Analysis page.